ARTICLE | Distillery Therapeutics
Therapeutics: Legumain (LGMN; AEP)
December 3, 2015 8:00 AM UTC
In vitro, patient sample and mouse studies suggest inhibiting LGMN could help treat AD. Levels of LGMN were higher in postmortem brain tissue samples from AD patients than from healthy controls. In a ...